Bone Biologics Corp Postpones 2026 Annual Meeting to Sept. 28

What Happened

• Bone Biologics Corporation (BBLG) announced on July 15, 2026 that its Board of Directors has postponed the 2026 annual meeting of stockholders, originally scheduled for August 11, 2026.
• The Annual Meeting will now be held on September 28, 2026 at 11:30 a.m. Eastern Time at the company’s offices (2 Burlington Woods Drive, Ste 100, Burlington, MA 01803).
• The Board said it will file a Definitive Proxy Statement on Schedule 14A that includes an additional proposal for stockholder vote and determined additional time was needed for stockholders to consider the proxy materials.

Key Details

• Board decision date: July 15, 2026.
• New Annual Meeting date/time: September 28, 2026 at 11:30 a.m. ET.
• New record date for voting: August 6, 2026.
• Deadline for stockholder submissions (director nominees or other proposals): ten calendar days after this Form 8-K filing — July 26, 2026.
• Company will file a Definitive Proxy Statement (Schedule 14A) to include the additional proposal.

Why It Matters

• The change alters the timeline for shareholder voting and engagement: the new record date and extended proxy period affect who can vote and give investors more time to review proxy materials.
• Shareholders who want to submit director nominees or other proposals must act by the new, short deadline (July 26, 2026).
• Investors should watch for the forthcoming Definitive Proxy Statement (Schedule 14A) for details on the added proposal and any potential effects on governance or corporate decisions.